Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
2007 Nov;48(2):141-4
The National Cancer Institute USA explored the feasibility of a weight loss intervention for breast cancer prevention clinical trial [26], and an endpoint of survivorship, rather than incidence was deemed most feasible and was pursued [26, 27]
Canada 13.5
Clinical context and dosing Thymosin alpha-1 is approved in more than 35 countries for the treatment of hepatitis B and C, giving it a well-established safety record
Asia-Pacific: Emerging markets in Singapore, India, Malaysia, and Russia are witnessing growth due to expanding pharmaceutical manufacturing and contract research organizations (CROs)
US$ 22.99
US$ 27.83
US$ 28.05
US$ 29.31
US$ 29.25
US$ 22.13
